We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2101
DELISTED
Cymabay Therapeutics
CBAY
| $173K | ﹤0.01% |
21,993
-18,603
| -46% | -$177K |
|
2102
Senseonics Holdings Inc
SENS
$366M
| $172K | ﹤0.01% |
3,328
-765
| -19% | -$51.1K |
|
2103
Koppers
KOP
$969M
| $171K | ﹤0.01% |
10,046
-12,330
| -55% | -$290K |
|
|
TWO
2104
Two Harbors Investment
TWO
$1.27B
| $171K | ﹤0.01% |
3,330
-6,772
| -67% | -$386K |
|
|
GLOG
2105
DELISTED
GASLOG LTD
GLOG
| $171K | ﹤0.01% |
10,401
-13
| -0.1% | -$259 |
|
|
VSLR
2106
DELISTED
VIVINT SOLAR, INC.
VSLR
| $171K | ﹤0.01% |
44,939
+14,307
| +47% | +$73.8K |
|
|
ACH
2107
Accendra Health
ACH
$214M
| $168K | ﹤0.01% |
26,481
| – | – |
|
2108
Energy Fuels
UUUU
$3.53B
| $168K | ﹤0.01% |
+58,871
| New | +$190K |
|
|
TDAY
2109
USA Today Co
TDAY
$1.06B
| $162K | ﹤0.01% |
13,978
+1,623
| +13% | +$22.7K |
|
2110
Accuray
ARAY
$34M
| $157K | ﹤0.01% |
45,901
+35,102
| +325% | +$142K |
|
2111
MBIA
MBI
$260M
| $156K | ﹤0.01% |
+17,501
| New | +$167K |
|
|
BRY
2112
DELISTED
Berry Corp
BRY
| $154K | ﹤0.01% |
+17,553
| New | +$236K |
|
|
CRZO
2113
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $154K | ﹤0.01% |
13,635
-6,368
| -32% | -$113K |
|
|
WIN
2114
DELISTED
Windstream Holdings Inc
WIN
| $153K | ﹤0.01% |
+73,181
| New | +$272K |
|
2115
Gaia
GAIA
$48.4M
| $150K | ﹤0.01% |
14,487
-21,598
| -60% | -$285K |
|
|
CISN
2116
DELISTED
Cision Ltd. Ordinary Share
CISN
| $150K | ﹤0.01% |
+12,782
| New | +$175K |
|
|
NEX
2117
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $146K | ﹤0.01% |
17,839
-63,104
| -78% | -$704K |
|
|
ATRS
2118
DELISTED
Antares Pharma, Inc.
ATRS
| $144K | ﹤0.01% |
53,034
-3,478
| -6% | -$11.5K |
|
2119
Travelzoo
TZOO
$75.4M
| $143K | ﹤0.01% |
14,569
| – | – |
|
|
QUOT
2120
DELISTED
Quotient Technology Inc
QUOT
| $138K | ﹤0.01% |
12,886
-3,840
| -23% | -$48.1K |
|
|
VSTO
2121
DELISTED
Vista Outdoor Inc.
VSTO
| $138K | ﹤0.01% |
+12,135
| New | +$159K |
|
2122
Savara
SVRA
$1.19B
| $137K | ﹤0.01% |
18,121
| – | – |
|
|
TVRD
2123
Tvardi Therapeutics
TVRD
$23.4M
| $137K | ﹤0.01% |
+293
| New | +$189K |
|
|
GOV
2124
DELISTED
Government Properties Income Trust
GOV
| $137K | ﹤0.01% |
19,894
-38,093
| -66% | -$339K |
|
|
VRAY
2125
DELISTED
ViewRay, Inc.
VRAY
| $136K | ﹤0.01% |
22,400
+4,020
| +22% | +$30.1K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.